keyword
https://read.qxmd.com/read/38533281/efficacy-of-pistacia-lentiscus-plant-rumi-mastagi-in-comparison-to-levosulpiride-in-patients-with-diabetic-gastroparesis-a-double-blind-non-inferior-randomised-control-trial-study
#1
JOURNAL ARTICLE
Ajaypal Singh, Ravi Kant, Rohit Raina, Vandana Dhingra, Rajeev Nema, Mukesh Chand Bairwa, Varsha Kanwar, Rifika L Sukhes Mukherjee, Anissa Atif Mirza, Mayank Agarwal
INTRODUCTION: Gastrointestinal neuropathies are frequently found in diabetic patients. The pathogenesis of diabetic gastroparesis (DG) is multifactorial. The usual treatment for DG includes dietary modifications, prokinetic and antiemetic agents. There is increasing demand for more effective medicines to treat DG. The current study was conducted on the Pistacia lentiscus stem extract to add to the armamentarium of DG treatment and to find the efficacy of P. lentiscus plant extract (mastic gum) in comparison to levosulpiride in DG for improvement in gastroparesis symptoms and gastric emptying scintigraphy (GES) in a single centric double-blind non-inferiority randomised control trial...
2024: Indian Journal of Endocrinology and Metabolism
https://read.qxmd.com/read/38523545/dopaminergic-drugs-and-valproate-associated-refractory-hyponatremia-over-levosulpiride-induced-parkinsonism-in-an-elderly-female-patient-when-deprescribing-was-the-only-therapy
#2
JOURNAL ARTICLE
Amol Dehade, Sankha Shubhra Chakrabarti, Not Taruni Srija Reddy, Upinder Kaur
INTRODUCTION: Prescribing cascade is a condition in which a drug administered to a patient causes an adverse reaction that is misinterpreted as a new condition, resulting in the addition of a new drug. CASE PRESENTATION: Here, we report the case of an elderly female patient who suffered from metabolic, neurologic, and urinary consequences of a prescribing cascade of antiemetic, antiepileptic, and dopaminergic drugs. While levosulpiride caused Parkinsonian symptoms, the dopaminergic drugs and valproate caused refractory hyponatremia followed by altered sensorium, and clidinium contributed to urinary retention...
March 20, 2024: Current Drug Safety
https://read.qxmd.com/read/38454589/fixed-drug-combination-levosulpiride-and-rabeprazole-induced-atypical-parkinsonian-s-disorders-with-associated-anxiety-and-low-lying-depression
#3
JOURNAL ARTICLE
Vishal R Tandon, Sheikh Hanan Ismail, Amarjeet Singh
We hereby describe a rare case of levosulpiride-induced atypical parkinsonism presenting with sluggish movements, atypical kinetic tremors (tremors with voluntary movement), periorbital tremors, dystonia, difficulty in speech and coordination, postural imbalance, with additional features of difficulty in swallowing and drooling with associated recent onset psychiatric disturbances such as anxiety and low-lying depression. The dechallenge of levosulpiride and medications for associated anxiety and low-lying depression caused a complete remission of the disease within 2 ½ months...
January 1, 2024: Indian Journal of Pharmacology
https://read.qxmd.com/read/38454582/real-world-safety-and-effectiveness-of-pistacia-lentiscus-mastic-gum-in-patients-with-diabetic-gastroparesis-24-week-interim-analysis-postintervention
#4
JOURNAL ARTICLE
Ravi Kant, Ajaypal Singh, Rohit Raina, Vandana Dhingra, Mukesh Bairwa, Varsha Kanwar
INTRODUCTION: Gastrointestinal neuropathies are frequently found in diabetic patients. AIM: The aim of this study was to find out the safety, adverse reactions, and long-term effectiveness of Pistacia lentiscus plant extract (mastic gum) in diabetic gastroparesis (DG) with respect to sustainable improvement in gastroparesis symptoms (Gastrointestinal Cardinal Symptom Index [GCSI] score) by observational follow-up study of a single-centric double-blind noninferiority randomized control trial...
January 1, 2024: Indian Journal of Pharmacology
https://read.qxmd.com/read/38024160/efficacy-of-prokinetic-agents-in-diabetic-gastroparesis-comparing-symptomatology-and-scintigraphy-an-open-label-trial
#5
JOURNAL ARTICLE
Ravi Kant, Madhuri Pratti, Meenakshi Khapre, Poonam Yadav, Vandana Dhingra
BACKGROUND: It is pertinent to objectively assess the severity of diabetic gastroparesis and tailor treatment accordingly. The current study was planned to document gastroparesis by gastric emptying scintigraphy (GES) objectively and see the effect of medications and diet control on clinical and GES after four weeks. METHODS: A prospective, open-label randomized trial was conducted in the Department of Internal Medicine at a tertiary care teaching hospital over twelve months...
2023: Caspian Journal of Internal Medicine
https://read.qxmd.com/read/37811050/lansoprazole-plus-levosulpiride-versus-esomeprazole-in-participants-with-gastroesophageal-reflux-disease-and-erosive-esophagitis-a-double-blinded-randomized-control-trial
#6
JOURNAL ARTICLE
Muhammad Rizwan Umer, Wendy E Mejia Crespo, Sana Dugan, Hamna Javed, Muhammad Suleman, Muhammad Waqas Afzal, Hassan Mumtaz, Muhammad Saqib, Haris Mumtaz Malik, Muhammad Iftikhar
AIM: The aim was to compare the efficacy and safety of lansoprazole plus levosulpiride over esomeprazole. METHODOLOGY: This randomized control trial recruited 1000 participants having symptomatic gastroesophageal reflux disease (GERD) and erosive esophagitis and they were blindly randomized into two groups in a 1:1 ratio with appropriate concealment. Group 1 was given lansoprazole plus levosulpiride combination twice daily whereas group 2 was prescribed only esomeprazole twice daily...
October 2023: Annals of Medicine and Surgery
https://read.qxmd.com/read/37765028/enhanced-antidepressant-activity-of-nanostructured-lipid-carriers-containing-levosulpiride-in-behavioral-despair-tests-in-mice
#7
JOURNAL ARTICLE
Sadia Tabassam Arif, Muhammad Ayub Khan, Shahiq Uz Zaman, Hafiz Shoaib Sarwar, Abida Raza, Muhammad Sarfraz, Yousef A Bin Jardan, Muhammad Umair Amin, Muhammad Farhan Sohail
The potential of levosulpiride-loaded nanostructured lipid carriers (LSP-NLCs) for enhanced antidepressant and anxiolytic effects was evaluated in the current study. A forced swim test (FST) and tail suspension test (TST) were carried out to determine the antidepressant effect whereas anxiolytic activity was investigated using light-dark box and open field tests. Behavioral changes were evaluated in lipopolysaccharide-induced depressed animals. The access of LSP to the brain to produce therapeutic effects was estimated qualitatively by using fluorescently labeled LSP-NLCs...
August 29, 2023: Pharmaceuticals
https://read.qxmd.com/read/37673971/levosulpiride-for-the-treatment-of-diabetic-macular-oedema-a-phase-2-randomized-clinical-trial
#8
RANDOMIZED CONTROLLED TRIAL
Carlos D Núñez-Amaro, Mariana López, Elva Adán-Castro, Ma Ludivina Robles-Osorio, Renata García-Franco, Marlon García-Roa, Yolanda Villalpando-Gómez, Paulina Ramírez-Neria, Nayeli Pineiro, Juan Fernando Rubio-Mijangos, Jorge Sánchez, Gabriela Ramírez-Hernández, Lourdes Siqueiros-Márquez, Nundehui Díaz-Lezama, Ellery López-Star, Thomas Bertsch, Gonzalo Marínez de la Escalera, Jakob Triebel, Carmen Clapp
BACKGROUND/OBJECTIVE: The prokinetic levosulpiride elevates vasoinhibin levels in the vitreous of patients with proliferative diabetic retinopathy (PDR) suggesting clinical benefits due to the anti-vasopermeability and anti-angiogenic properties of vasoinhibin. We investigated the biological activity of levosulpiride in centre-involving diabetic macular oedema (DME). PATIENTS/METHODS: Prospective, randomized, double-blinded, dual-centre, phase 2 trial in patients with centre-involving DME orally treated with placebo (n = 17) or levosulpiride (n = 17) for 8 weeks or in patients with PDR undergoing elective pars plana vitrectomy and receiving placebo (n = 18) or levosulpiride (n = 18) orally for the 1 week before vitrectomy...
February 2024: Eye
https://read.qxmd.com/read/37665080/a-comparison-of-different-symptomatic-reflux-esophagitis-treatments-a-real-world-study
#9
JOURNAL ARTICLE
Francesco Di Mario, Pellegrino Crafa, Lorella Franzoni, Antonio Tursi, Giovanni Brandimarte, Michele Russo, Kryssia Isabel Rodriguez-Castro, Marilisa Franceschi, Nicola De Bortoli, Edoardo Savarino
BACKGROUND: Proton pump inhibitors (PPIs) are currently the reference drugs for gastroesophageal reflux disease (GERD), but symptoms often recur after their withdrawal. Moreover, whether prokinetics or barrier drugs used alongside PPIs are more effective remains under debate. OBJECTIVES: The aim of the study was to assess the efficacy of different therapeutic approaches to GERD treatment. MATERIAL AND METHODS: We enrolled 211 grade A reflux esophagitis patients who consented to participate in this non-randomized, open-label trial...
September 4, 2023: Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University
https://read.qxmd.com/read/37065352/pharmacoeconomic-analysis-of-fixed-dose-combinations-of-proton-pump-inhibitors-available-in-india
#10
JOURNAL ARTICLE
Pradnya Deolekar, Kavita Vivek, Souvik Ghosh, Azra Naseem, Mayakalyani Srivathsan, Vivek S Rai, Sonal Signapurkar, Pramila Yadav
Introduction The global proton pump inhibitors (PPIs) market was valued at US$ 2.9 billion in 2020 and is expected to exhibit a compound aggregated growth rate of 4.30% during the forecast period (2020-2027), as they are regularly prescribed for many gastrointestinal disorders, and the treatment usually lasts for a longer period. PPIs are usually combined with antiemetics and prokinetic drugs. The price of PPIs for the same combination varies a lot, which can lead to a lot of financial burden on the patients...
March 2023: Curēus
https://read.qxmd.com/read/36975662/qbd-based-approach-to-optimize-niosomal-gel-of-levosulpiride-for-transdermal-drug-delivery
#11
JOURNAL ARTICLE
Ahmed S Alnaim, Hiral Shah, Anroop B Nair, Vivek Mewada, Smit Patel, Shery Jacob, Bandar Aldhubiab, Mohamed A Morsy, Rashed M Almuqbil, Pottathil Shinu, Jigar Shah
Poor aqueous solubility besides extensive hepatic first effect significantly decreases the oral absorption of levosulpiride, which in turn minimizes its therapeutic effectiveness. Niosomes have been extensively investigated as a transdermal vesicular nanocarrier to increase the delivery of low permeable compounds into and across the skin. This research work was to design, develop and optimize levosulpiride-loaded niosomal gel and to evaluate its prospects for transdermal delivery. The Box-Behnken design was used to optimize niosomes by analyzing the impact of three factors (cholesterol; X1 , Span 40; X2 , and sonication time; X3 ) on the responses (particle size, Y1 , and entrapment efficiency, Y2 )...
March 10, 2023: Gels
https://read.qxmd.com/read/36842175/neuromodulating-agents-in-functional-dyspepsia-a-comprehensive-review
#12
REVIEW
L Bosman, L Wauters, T Vanuytsel
BACKGROUND AND STUDY AIMS: Functional dyspepsia is a common chronic condition with upper abdominal symptoms in the absence of an organic cause. The first line treatment consists of protonpomp inhibition or Helicobacter pylori eradication. However, this approach often does not provide enough symptom relief. Neuromodulating agents are commonly used in clinical practice but only tricyclic antidepressant (TCAs) are mentioned in European and American and Canadian guidelines. METHODS: We performed a comprehensive review of the literature in Pubmed for full-text randomized controlled trials in English with adult participants (>18 years) who met the Rome II, III or IV criteria or were diagnosed by a physician with a negative upper endoscopy and that compared a neuromodulating agent with placebo...
2023: Acta Gastro-enterologica Belgica
https://read.qxmd.com/read/36714973/do-prokinetic-agents-provide-symptom-relief-through-acceleration-of-gastric-emptying-an-update-and-revision-of%C3%A2-the-existing-evidence
#13
JOURNAL ARTICLE
Nick Goelen, Mike Jones, I-Hsuan Huang, Florenca Carbone, Pieter Janssen, Jan Tack
BACKGROUND: Gastroparesis and functional dyspepsia are disorders characterized by upper gastrointestinal symptoms and multifaceted etiologies. One of the main therapeutic approaches is accelerating gastric emptying (GE) by means of prokinetic agents. Their efficacy has been demonstrated, although the association between symptom improvement and acceleration of emptying is less clear. Meta-analyses have found contradictory results. Differences in applied methodology and included trials might drive these contradictions...
January 30, 2023: United European Gastroenterology Journal
https://read.qxmd.com/read/36396112/levosulpiride-loaded-nanostructured-lipid-carriers-for-brain-delivery-with-antipsychotic-and-antidepressant-effects
#14
JOURNAL ARTICLE
Summaira Maqsood, Fakhar Ud Din, Saif Ullah Khan, Ehsan Elahi, Zakir Ali, Hamzah Jamshaid, Alam Zeb, Tunazza Nadeem, Wajid Ahmad, Salman Khan, Han Gon Choi
AIMS: Herein, we investigate the potential of levosulpiride-loaded nanostructured lipid carriers (LEVO-NLCs) for effective brain delivery with anti-psychotic and antidepressant effects. MAIN METHODS: Micro-emulsion method was used to prepare LEVO-NLCs, followed by its optimization using Design Expert®, investigation of the particles properties and entrapment efficiency (%EE). Moreover, in-vitro release, in-vivo plasma and brain kinetic studies of LEVO-NLCs were executed...
November 14, 2022: Life Sciences
https://read.qxmd.com/read/36365165/augmented-oral-bioavailability-and-prokinetic-activity-of-levosulpiride-delivered-in-nanostructured-lipid-carriers
#15
JOURNAL ARTICLE
Sadia Tabassam Arif, Shahiq Uz Zaman, Muhammad Ayub Khan, Tanveer A Tabish, Muhammad Farhan Sohail, Rabia Arshad, Jin-Ki Kim, Alam Zeb
The present study is aimed to develop and optimize levosulpiride-loaded nanostructured lipid carriers (LSP-NLCs) for improving oral bioavailability and prokinetic activity of LSP. LSP-NLCs were optimized with D-optimal mixture design using solid lipid, liquid lipid and surfactant concentrations as independent variables. The prepared LSP-NLCs were evaluated for physicochemical properties and solid-state characterization. The in vivo oral pharmacokinetics and prokinetic activity of LSP-NLCs were evaluated in rats...
October 31, 2022: Pharmaceutics
https://read.qxmd.com/read/36171930/widening-spectrum-of-neuroleptic-malignant-syndrome-case-series
#16
Gunchan Paul, Sachi Singhal, Birinder S Paul, Gurparvesh Singh, Shriya Goyal
Neuroleptic malignant syndrome (NMS) is a rare and rapidly progressive syndrome with mortality rate of 5.6%. The spectrum of onset, progression and outcome is heterogeneous and is associated with number of risk factors. In our case series, we entail the triggers, hospital course and outcome of five interesting in-patient cases that were admitted to our service in a tertiary care hospital in Northern India. This case series is to highlight the first ever reported case of NMS triggered by levosulpiride administration, along with one of the few first cases of NMS after programming of DBS, hypothyroid disorders, levodopa readjustment and selective basal ganglia and cerebellar injury following the hyperthermic syndrome...
April 2022: Journal of Anaesthesiology, Clinical Pharmacology
https://read.qxmd.com/read/36157442/prolactin-and-vasoinhibin-are-endogenous-players-in-diabetic-retinopathy-revisited
#17
REVIEW
Jakob Triebel, Thomas Bertsch, Carmen Clapp
Diabetic retinopathy (DR) and diabetic macular edema (DME) are major causes for visual loss in adults. Nearly half of the world's population with diabetes has some degree of DR, and DME is a major cause of visual impairment in these patients. Severe vision loss occurs because of tractional retinal detachment due to retinal neovascularization, but the most common cause of moderate vision loss occurs in DME where excessive vascular permeability leads to the exudation and accumulation of extracellular fluid and proteins in the macula...
2022: Frontiers in Endocrinology
https://read.qxmd.com/read/36154321/levosulpiride-for-premature-ejaculation-a-systematic-review-and-meta-analysis
#18
REVIEW
Adina Arshad, Muhammad Irfan, Muhammad Inam, Nik Hazlina Nik Hussain, Shaiful Bahari Ismail
Premature ejaculation (PE) is one of the major causes of sexual dysfunction. Levosulpiride is an off-label medicine used to treat PE, but no review on its efficacy exists. A systematic review and meta-analysis was performed to determine the efficacy of levosulpiride in treating PE. Databases PubMed, Science Direct, and Google Scholar were searched. Randomized control trials (RCTs) comparing levosulpiride with placebo or other medicine were selected. Odds ratio (OR) of improved intravaginal ejaculation latency time (IELT) was calculated...
2022: American Journal of Men's Health
https://read.qxmd.com/read/35078262/sulpiride-induced-hyperprolactinaemia-increases-retinal-vasoinhibin-and-protects-against-diabetic-retinopathy-in-rats
#19
JOURNAL ARTICLE
Elva Adán-Castro, Lourdes Siqueiros-Márquez, Gabriela Ramírez-Hernández, Nundehui Díaz-Lezama, Xarubet Ruíz-Herrera, Francisco Freinet Núñez, Carlos D Núñez-Amaro, Ma Ludivina Robles-Osorio, Thomas Bertsch, Jakob Triebel, Gonzalo Martínez de la Escalera, Carmen Clapp
Excessive vasopermeability and angiogenesis compromise vision in diabetic macular oedema (DME) and diabetic retinopathy (DR). Vasoinhibin is a fragment of the hormone prolactin (PRL) that inhibits diabetes-induced retinal hypervasopermeability and ischaemia-induced retinal angiogenesis in rodents. Hyperprolactinaemia generated by the dopamine D2 receptor antagonist, levosulpiride, is associated with higher levels of vasoinhibin in the vitreous of patients with DR, implying a beneficial outcome due to vasoinhibin-mediated inhibition of retinal vascular alterations...
April 2022: Journal of Neuroendocrinology
https://read.qxmd.com/read/34398289/mascc-antiemetics-in-advanced-cancer-updated-guideline
#20
JOURNAL ARTICLE
Mellar Davis, David Hui, Andrew Davies, Carla Ripamonti, Andreia Capela, Giulia DeFeo, Egidio Del Fabbro, Eduardo Bruera
BACKGROUND: Nausea and vomiting are a common clinical symptom in the advanced cancer patient. Pharmacologic management is important. Evidence for drug choices and guidelines are needed to help clinicians manage nausea and vomiting in this population METHODS: Evidence from a systematic review published in 2010, initial MASCC guidelines developed from a systematic review of literature to 2015, and a new systematic review of randomized trials published between 2015 and February 2, 2021, was combined to establish a new guideline...
December 2021: Supportive Care in Cancer
keyword
keyword
115608
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.